| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Takeda Y | |
| Yamasaki S | |||
| Kurazono H | |||
| P2860 | cites work | Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron | Q42859529 |
| Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. | Q43730279 | ||
| Detection of entero- and verocyto-toxin genes in Escherichia coli from diarrhoeal disease in animals using the polymerase chain reaction | Q44539876 | ||
| Characterization of purified Shiga toxin from Shigella dysenteriae 1. | Q44635809 | ||
| Mutations affecting the activity of the Shiga-like toxin I A-chain | Q44645523 | ||
| Ribosome-inhibiting proteins, retroviral reverse transcriptases, and RNase H share common structural elements | Q45244947 | ||
| Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome | Q48160670 | ||
| Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin | Q53985711 | ||
| Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. | Q54385143 | ||
| A nested PCR followed by magnetic separation of amplified fragments for detection of Escherichia coli Shiga-like toxin genes | Q54688211 | ||
| Crystallization of the B chain of Shiga-like toxin I from Escherichia coli. | Q54697962 | ||
| Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin. | Q54739376 | ||
| Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. | Q54755738 | ||
| Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. | Q54763750 | ||
| Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. | Q54765418 | ||
| Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2) | Q57563891 | ||
| Escherichia colistrains isolated from pigs with edema disease produce a variant of Shiga-like toxin II | Q57563893 | ||
| Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933 | Q57563895 | ||
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli | Q27644365 | ||
| Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
| Demonstration of RNA N-glycosidase activity of a Vero toxin (VT2 variant) produced by Escherichia coli O91:H21 from a patient with the hemolytic uremic syndrome | Q33397317 | ||
| Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent | Q33453483 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family | Q34050888 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. | Q34258393 | ||
| Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli | Q34633814 | ||
| Nucleotide sequence of cloned cDNA coding for preproricin | Q36485194 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit | Q36785336 | ||
| Structure-function analyses of Shiga toxin and the Shiga-like toxins | Q37947130 | ||
| Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. | Q38334562 | ||
| Cytotoxic enteropathogenic Escherichia coli | Q39579148 | ||
| The Pathogenesis of Shigella Diarrhea. V. Relationship of Shiga Enterotoxin, Neurotoxin, and Cytotoxin | Q40317423 | ||
| Genomic cloning and characterization of a ricin gene from Ricinus communis | Q40472529 | ||
| Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli | Q42653384 | ||
| Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli | Q42657348 | ||
| P433 | issue | 8 | |
| P921 | main subject | Escherichia coli | Q25419 |
| Verocytotoxin | Q7922328 | ||
| P304 | page(s) | 591-599 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli). | |
| P478 | volume | 37 |
| Q35931774 | A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo |
| Q34065066 | A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. |
| Q35487599 | Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice |
| Q33332657 | Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin |
| Q92990589 | Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system |
| Q35220829 | Comparison of a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to pulsed-field gel electrophoresis to determine the effect of repeated subculture and prolonged storage on RFLP patterns of Shiga toxin-producing Escherichia coli O157:H7 |
| Q54645159 | Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. |
| Q47722428 | Cytotoxin produced by Escherichia coli isolated from chickens with swollen head syndrome (SHS). |
| Q73195913 | Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol |
| Q37597530 | Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli |
| Q42598416 | Distinctiveness of the genomic sequence of Shiga toxin 2-converting phage isolated from Escherichia coli O157:H7 Okayama strain as compared to other Shiga toxin 2-converting phages |
| Q24596619 | Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives |
| Q73207396 | Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157:H7 |
| Q37618214 | Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease. |
| Q38927469 | Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2. |
| Q54323381 | Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production. |
| Q33659662 | Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. |
| Q35946861 | Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin |
| Q33967696 | Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan |
| Q73209521 | Shiga toxin activates p38 MAP kinase through cellular Ca(2+) increase in Vero cells |
| Q74609189 | Shiga toxins |
| Q73249344 | Simple and rapid bioluminescent detection of two verotoxin genes using allele-specific PCR of E. coli O157: H7 |
| Q43987598 | Simultaneous detection of two verotoxin genes using dual-label time-resolved fluorescence immunoassay with duplex PCR. |
| Q54645163 | Specific detection of a verotoxin 2 variant, VT2vp1, by a bead-enzyme-linked immunosorbent assay. |
Search more.